第 1 到 9 筆結果,共 9 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2015 | Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy | KUAN-YIN LIN ; SIH-HAN LIAO ; Liu W.-C.; ARISTINE CHENG ; SHU-WEN LIN ; SUI-YUAN CHANG ; Tsai M.-S.; CHING-HUA KUO ; Wu M.-R.; HSIU-PO WANG ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | PLoS ONE | 14 | 10 | |
2 | 2020 | Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study | Huang S.-H.; SHU-WEN LIN ; SUI-YUAN CHANG ; Lin Y.-T.; HSIN-YUN SUN ; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 4 | 4 | |
3 | 2021 | Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV | Huang, Sung-Hsi; Huang, Wei-Chieh; SHU-WEN LIN ; YU-CHUNG CHUANG ; HSIN-YUN SUN ; SUI-YUAN CHANG ; Kuo, Po-Hsien; Wu, Pei-Ying; Liu, Wen-Chun; Chiang, Chieh; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of acquired immune deficiency syndromes (1999) | 7 | 4 | |
4 | 2014 | Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan | Tseng Y.-T.; Yang C.-J.; SUI-YUAN CHANG ; SHU-WEN LIN ; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | International Journal of Infectious Diseases | 12 | 10 | |
5 | 2017 | Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients | YU-SHAN HUANG ; CHIEH-KAI CHAN ; Tsai M.-S.; Lee K.-Y.; SHU-WEN LIN ; SUI-YUAN CHANG ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 12 | 8 | |
6 | 2017 | Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy | Huang S.-H.; SHU-WEN LIN ; SUI-YUAN CHANG ; Lin Y.-T.; Chiang C.; Hsiao C.-F.; HSIN-YUN SUN ; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Scientific Reports | 7 | 7 | |
7 | 2015 | Presence of tablet remnants of nevirapine extended-release in stools and its impact on virological outcome in HIV-1-infected patients: A prospective cohort study | Lee Y.-C.; SHU-WEN LIN ; Chen M.-Y.; SUI-YUAN CHANG ; CHING-HUA KUO ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; HSIN-YUN SUN ; Chang H.-Y.; Wu M.-R.; Liu W.-C.; Wu P.-Y.; Yang S.-P.; Zhang J.-Y.; Su Y.-C.; Luo Y.-Z.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | PLoS ONE | 1 | 0 | |
8 | 2014 | Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy | Lee K.-Y.; SHU-WEN LIN ; HSIN-YUN SUN ; CHING-HUA KUO ; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; SUI-YUAN CHANG ; CHIEN-CHING HUNG | PLoS ONE | 24 | 25 | |
9 | 2017 | Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study | Tsai M.-S.; SUI-YUAN CHANG ; SHU-WEN LIN ; CHING-HUA KUO ; HSIN-YUN SUN ; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 5 | 3 |